Autologous stem cell transplant for multiple myeloma patients 70 years or older
Eli Muchtar(Mayo Clinic), Morie A. Gertz(Medical University of South Carolina), Rajshekhar Chakraborty(Columbia University Irving Medical Center), Francis K. Buadi, Robert Christian Wolf(Heidelberg University), Nelson Leung(WinnMed), Shaji Kumar(Mayo Clinic), Prashant Kapoor, S. Vincent Rajkumar(WinnMed), Martha Q. Lacy(Mayo Clinic), William J. Hogan(Mayo Clinic), D A Gastineau(Mayo Clinic in Arizona), Angela Dispenzieri(Mayo Clinic), Suzanne R. Hayman, David Dingli
Cited by 63
Related Papers
International uniform response criteria for multiple myeloma
|Leukemia|2006|2.6k
Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group
|Journal of Clinical Oncology|2015|2.2k
Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis
|Circulation|2016|2k
CRITERIA FOR EVALUATING DISEASE RESPONSE AND PROGRESSION IN PATIENTS WITH MULTIPLE MYELOMA TREATED BY HIGH‐DOSE THERAPY AND HAEMOPOIETIC STEM CELL TRANSPLANTATION
|British Journal of Haematology|1998|1.5k